These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35535787)

  • 1. Competing Responses to Global Inequalities in Access to COVID Vaccines: Vaccine Diplomacy and Vaccine Charity Versus Vaccine Liberty.
    Sparke M; Levy O
    Clin Infect Dis; 2022 Aug; 75(Suppl 1):S86-S92. PubMed ID: 35535787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Vaccine Diplomacy and Equitable Access to Vaccines Amid Ongoing Pandemic.
    Sharun K; Dhama K
    Arch Med Res; 2021 Oct; 52(7):761-763. PubMed ID: 33941393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVAX, vaccine donations and the politics of global vaccine inequity.
    de Bengy Puyvallée A; Storeng KT
    Global Health; 2022 Mar; 18(1):26. PubMed ID: 35248116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Vaccine, TRIPS, and Global Health Diplomacy: India's Role at the WTO Platform.
    Chattu VK; Singh B; Kaur J; Jakovljevic M
    Biomed Res Int; 2021; 2021():6658070. PubMed ID: 34485525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redressing COVID-19 vaccine inequity amidst booster doses: charting a bold path for global health solidarity, together.
    Rackimuthu S; Narain K; Lal A; Nawaz FA; Mohanan P; Essar MY; Charles Ashworth H
    Global Health; 2022 Feb; 18(1):23. PubMed ID: 35193616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. China's Vaccine Diplomacy and Its Implications for Global Health Governance.
    Liu L; Huang Y; Jin J
    Healthcare (Basel); 2022 Jul; 10(7):. PubMed ID: 35885803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccines: the imperfect instruments of vaccine diplomacy.
    Hotez PJ
    J Travel Med; 2022 Dec; 29(8):. PubMed ID: 35608393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing African Medicines Agency through Global Health Diplomacy for an Equitable Pan-African Universal Health Coverage: A Scoping Review.
    Chattu VK; Dave VB; Reddy KS; Singh B; Sahiledengle B; Heyi DZ; Nattey C; Atlaw D; Jackson K; El-Khatib Z; Eltom AA
    Int J Environ Res Public Health; 2021 Nov; 18(22):. PubMed ID: 34831511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can we move beyond vaccine apartheid? Examining the determinants of the COVID-19 vaccine gap.
    Forman L; Jackson C; Fajber K
    Glob Public Health; 2023 Jan; 18(1):2256822. PubMed ID: 37715686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charity or empowerment? The role of COVAX for low and middle-income countries.
    Holzer F; Roa TM; Germani F; Biller-Andorno N; Luna F
    Dev World Bioeth; 2023 Mar; 23(1):59-66. PubMed ID: 35307947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital vaccine passports and digital health diplomacy: an online model WHO simulation.
    Godinho MA; Liaw ST; Kanjo C; Marin HF; Martins H; Quintana Y
    J Am Med Inform Assoc; 2023 Mar; 30(4):712-717. PubMed ID: 35866622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Pandemic as an Excellent Opportunity for Global Health Diplomacy.
    Taghizade S; Chattu VK; Jaafaripooyan E; Kevany S
    Front Public Health; 2021; 9():655021. PubMed ID: 34322467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Vaccine Donations-Vaccine Empathy or Vaccine Diplomacy? A Narrative Literature Review.
    Su Z; McDonnell D; Li X; Bennett B; Šegalo S; Abbas J; Cheshmehzangi A; Xiang YT
    Vaccines (Basel); 2021 Sep; 9(9):. PubMed ID: 34579261
    [No Abstract]   [Full Text] [Related]  

  • 14. Designing the global vaccine supply chain: balancing intellectual property rights with post COVID-19 vaccine equity.
    Park SP; Lee HJ; Yu Y; Lee EYJ; Park YS
    BMJ Glob Health; 2023 Nov; 8(11):. PubMed ID: 38035734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expertise as a Response to Limited Multilateralism: The Case of South Korea's Vaccine Procurement Task Force for COVID-19 Vaccines amid Unequal Access via the COVAX Facility.
    Park J
    J Health Polit Policy Law; 2024 Feb; 49(1):99-132. PubMed ID: 37522333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prioritizing 'equity' in COVID-19 vaccine distribution through Global Health Diplomacy.
    Singh B; Chattu VK
    Health Promot Perspect; 2021; 11(3):281-287. PubMed ID: 34660222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunizations and vaccines: a decade of successes and reversals, and a call for 'vaccine diplomacy'.
    Hotez PJ
    Int Health; 2019 Sep; 11(5):331-333. PubMed ID: 31034023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
    So AD; Woo J
    BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pandemics, intellectual property and 'our economy': A worldview analysis of Canada's role in compromising global access to COVID-19 vaccines.
    Brisbois B; Plamondon K; Walugembe D; Pereira RC; Edet C; Dixon J; Habibi R; Karamouzian M; Labonté R; Murthy S; Ravitsky V
    Glob Public Health; 2024 Jan; 19(1):2335360. PubMed ID: 38626321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine.
    Sekalala S; Forman L; Hodgson T; Mulumba M; Namyalo-Ganafa H; Meier BM
    BMJ Glob Health; 2021 Jul; 6(7):. PubMed ID: 34253631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.